Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (73)

Latest Posts

About This Stock More About This Stock
5 Beaten Down Stocks Of Spooky October With Upside Potential
Article By: Sweta Killa
Thursday, November 1, 2018 12:30 PM EST
Here are five stocks from the S&P 500 Index that were hit badly by market turmoil but might reverse the trend. These stocks saw positive earnings estimate revisions last month.
In this article: AMZN, NFX, BMY, ETN, CF Also: MSFT, NVDA, FB, AAPL
Read
Bristol-Myers Squibb Is Prepared To Heal Itself
Article By: Fredrik Arnold
Friday, October 19, 2018 5:50 AM EST
BMY's price per share was $56.02 at yesterday's market close. A year ago its price was $63.70 for a price loss of $7.68 per share for the year.
In this article: BMY
Read
AI And The New Health Care
Article By: John Thomas
Friday, September 28, 2018 3:34 AM EST
The first major industry to be fundamentally disrupted by AI will be health care. The next step in our intellectual evolution will be carried out by AI. By connecting our neocortex to the Internet, we will greatly improve our intelligence.
In this article: BMY, MRK, PFE, XLV, XPH
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich
Saturday, July 28, 2018 9:15 PM EST
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read
Week In Review: Long Hill Capital Closes $265 Million Fund For China Healthcare
Article By: ChinaBio® Today
Saturday, July 28, 2018 4:14 PM EST
Long Hill Capital of Beijing and Shanghai, focused the healthcare and consumer sectors, closed its second fund at $265 million. Long Hill said it "significantly exceeded” its funding target, showing the success of its thesis-investing strategy.
In this article: BMY, MRK, SNY, CELG, BGNE
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!

$BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 1 of 1 comments